Supply Chain Visibility & Control-Drug Shortages Part II | Updates will be provided by the FDA on efforts and initiatives developed during the current COVID-19 pandemic to secure the supply chain of critical drugs intended for the US. Current problems have been identified related to the illegal sale of drugs through the internet being marketed to treat COVID-19. In addition, the agency is dealing with everything from a shortage of hand sanitizers in the US, to how pharmacy compounding is being affected by the current pandemic, and the efforts of the FDA Drug Shortages team in mitigating shortages. Attendees will have an opportunity to hear first-hand the challenges the agency faces and the process to ensure that critical drugs are made available to patients during a pandemic and how industry can assist in reducing potential shortages.
Director, Division of Drug Quality I,